No photo available
Apr 12, 2019 — Specialty Pharmacy for sale in New York City.
The company has a long-standing presence and reputation within the surrounding metropolitan areas and is strategically positioned next to key highways, bridges, and subway lines. Their Specialty focus includes Oncology (45% of revenue), Rheumatoid Arthritis/Osteoarthritis, Biologics, Transplant, and an assortment of other diverse, specialized pharmaceutical needs. There is also a small retail component to the business.
The pharmacy accepts all major payers, including PBM Commercial, Medicare Part D, Medicaid HMO, Medicaid, and cash. Nearly 45% of their revenue comes from their Oncology Specialty. In 2018, they generated $52.5 Million in gross revenue with an adjusted EBITDA of $1,947,466 (3.71%) and are on track to generate $56 million of revenue in 2019.
There is a full complement of staff that is expected to stay on post-acquisition. The sellers will assist during a transitional period as needed and consider staying on long-term.
The asking price for this opportunity is $14 Million plus the cost of inventory.